ResearcherActive in the last 2 years

Eunji Hong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0695-1275; OpenAlex author ID A5011524152. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer. Co-author DOI 10.1038/s41388-026-03871-0 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ja‐Lok Ku · 1 shared paper, 2026 · strength 0.22
- Paper ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer. DOI 10.1038/s41388-026-03871-0 ↗
Seong‐Jin Kim · 1 shared paper, 2026 · strength 0.22
- Paper ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer. DOI 10.1038/s41388-026-03871-0 ↗
Toshikazu Ushijima · 1 shared paper, 2026 · strength 0.22
- Paper ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer. DOI 10.1038/s41388-026-03871-0 ↗
Daechan Park · 1 shared paper, 2026 · strength 0.22
- Paper ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer. DOI 10.1038/s41388-026-03871-0 ↗
Wooil Kwon · 1 shared paper, 2026 · strength 0.22
- Paper ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer. DOI 10.1038/s41388-026-03871-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.